| 000 | 01459 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515172122.0 | ||
| 264 | 0 | _c20090605 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1079-7440 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGupta, Vishal | |
| 245 | 0 | 0 |
_aDevelopment of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug. _h[electronic resource] |
| 260 |
_bPDA journal of pharmaceutical science and technology _c |
||
| 300 |
_a58-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aCalorimetry, Differential Scanning |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aFamotidine _xadministration & dosage |
| 650 | 0 | 4 |
_aHistamine H2 Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPowder Diffraction |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSpectroscopy, Fourier Transform Infrared |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aXylitol _xchemistry |
| 700 | 1 | _aGupta, Meenal | |
| 700 | 1 | _aMadan, Anil Kumar | |
| 773 | 0 |
_tPDA journal of pharmaceutical science and technology _gvol. 63 _gno. 1 _gp. 58-70 |
|
| 999 |
_c18882669 _d18882669 |
||